Iovance Biotherapeutics Inc (IOVA) support and resistance · rev $170.7M
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
This page maps Iovance Biotherapeutics Inc (IOVA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
IOVA currently screens at market cap $1.89B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IOVA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IOVA quote page for the session range and the stock page for the full model.
Not investment advice.